FIELD: medicine.
SUBSTANCE: for treatment of dangerous neuroviral infections, mice are injected with Moliksan® in a single dose of 20.0 mg/kg of body weight immediately after infection and after 24, 48, 72 hours.
EFFECT: increased effectiveness of combating diseases caused by pathogens of dangerous neuroviral infections.
6 tbl
Title | Year | Author | Number |
---|---|---|---|
AZOLOAZINE SALTS OF FLUOROQUINOLONES, POSSESSING ANTIBACTERIAL AND ANTIVIRAL ACTION | 2014 |
|
RU2547835C1 |
VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY | 2012 |
|
RU2476205C1 |
PALLADIUM-COPPER CATALYSTS FOR HOMOGENEOUS SELECTIVE OXIDATION OF THIOL GROUPS, COMBINATION AND COMPOSITION BASED ON SAID CATALYSTS AND THERAPEUTIC TREATMENT METHOD | 2011 |
|
RU2451010C1 |
METHOD AND AGENT ACTIVATING IRF-3 FOR TREATING AND PREVENTING DISEASES CAUSED BY (+) RNA CONTAINING VIRUSES | 2012 |
|
RU2518314C2 |
METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
ANTIVIRAL IMMUNOMODULATING AGENT | 2001 |
|
RU2202547C2 |
ANIMAL MODELING OF HEMORRHAGIC NEPHROSONEPHRITIS DISEASE CAUSED BY HANTAAN VIRUS | 2005 |
|
RU2294563C2 |
STRAIN C/2014 OF MACHUPO VIRUS - AGENT OF BOLIVIAN HAEMORRHAGIC FEVER INTENDED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICAL REMEDIES IN RESPECT OF THIS PATHOGEN | 2017 |
|
RU2699525C2 |
METHOD OF PREPARING ANTIBODIES FOR MITE ENCEPHALITIS VIRUS DIAGNOSTIC PREPARATION PRODUCTION | 1993 |
|
RU2063245C1 |
Authors
Dates
2018-01-24—Published
2016-09-20—Filed